Scienture Holdings (SCNX) Quick Ratio

This price chart from the GURU.Markets platform illustrates the price action of Scienture Holdings Inc (SCNX), where the liquidity ratio stands at 3.06. The business focuses on creating advanced drug formulations for the treatment of cancer and nervous system disorders to improve bioavailability. Stability is provided by the development of software for hospital archives, while the protection of its market niche is guaranteed by patents for substance delivery systems, despite limited sales.

This indicator measures the ability of Scienture Holdings Inc (SCNX) to immediately settle short-term debts using cash and accounts receivable, completely excluding low-liquidity inventories. The current value of 3.06 confirms the financial stability of the model, where cloud outsourcing minimizes the need for capital assets, as clearly reflected through the change in the quick ratio.